<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05026476</url>
  </required_header>
  <id_info>
    <org_study_id>RJ1</org_study_id>
    <nct_id>NCT05026476</nct_id>
  </id_info>
  <brief_title>Acceptability and Tolerance Study of a Thickener for Those Ages 6 Months and Above</brief_title>
  <official_title>Evaluation of the Acceptability (Including Gastrointestinal Tolerance, Compliance) of a Thickener for Those Aged 6 Months and Above.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nestlé</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nestlé</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, acceptability study to evaluate the gastrointestinal tolerance and&#xD;
      compliance of a thickener for the management of reflux, GORD and dysphagia&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To evaluate the gastrointestinal tolerance and compliance of a thickener for 7 days for the&#xD;
      submission to the Advisory Committee for Borderline Substances (ACBS).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 16, 2021</start_date>
  <completion_date type="Anticipated">October 16, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 16, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Gastrointestinal tolerance</measure>
    <time_frame>7 days</time_frame>
    <description>Measure using daily diary</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Participant compliance</measure>
    <time_frame>7 days</time_frame>
    <description>Daily intake using diary</description>
  </secondary_outcome>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Dysphagia</condition>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Resource Thicken up Junior</intervention_name>
    <description>Each infant and child will be switch over to receive for a period of 7 days (new thickener)</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        infants and children&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        I. Infants and children aged 6 months and over who require a thickener for reflux, GORD,&#xD;
        dysphagia II. Infants and children already on a thickener for the management of reflux,&#xD;
        GORD and dysphagia III. Parents to avoid introducing new weaning/ new foods (for the older&#xD;
        infants) whilst on the thickener for 1 week when measuring GI tolerance and thickener&#xD;
        intake IV. Willingly given, written, informed consent from patient or parent/guardian&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        I. Inability to comply with the study protocol, in the opinion of the investigator.&#xD;
&#xD;
        II. Contraindications to any feed ingredients (see nutritional table and ingredients list)&#xD;
        III. Allergy to milk (thickener is made in a factory that handles milk) IV. Children under&#xD;
        the age of 6 months of age V. Emergencies VI. Participation in another interventional study&#xD;
&#xD;
        -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>16 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Analou Sugar</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chelsea and Westminster</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>S Saduera, BSc</last_name>
    <phone>07557170649</phone>
    <email>sharan.saduera@uk.nestle.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Analou Sugar</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Chelsea and Westminster Hospital Foundation Trust</name>
      <address>
        <city>London</city>
        <zip>SW10 9NH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Analou Sugar</last_name>
      <email>analou.sugar@nhs.net</email>
    </contact>
    <contact_backup>
      <last_name>S Saduera</last_name>
      <email>sharan.saduera@uk.nestle.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 24, 2021</study_first_submitted>
  <study_first_submitted_qc>August 24, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 30, 2021</study_first_posted>
  <last_update_submitted>August 24, 2021</last_update_submitted>
  <last_update_submitted_qc>August 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Deglutition Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

